EPIRUS Biopharmaceuticals, Inc. announced the appointment of Thomas Shea as Chief Financial Officer (CFO). As CFO, Mr. Shea will oversee EPIRUS' financial planning and analysis, technical accounting, controllership, treasury, tax, insurance, investor relations, human resources and facilities functions. Mr. Shea brings almost 30 years of experience leading finance organizations, directing fund raising activities, structuring complex partnerships, and planning and executing IPO activities for high growth biopharmaceutical companies.

Most recently, he served as CFO and Treasurer of Euthymics Bioscience, Neurovance Inc, and EBI Life Sciences, three privately held, affiliated companies.